日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance

利用曲妥珠单抗-美坦新在HER2阳性乳腺癌细胞系中进行CRISPR筛选,揭示了耐药性的新机制。

Lipert, Barbara A; Siemens, Kyla N; Khan, Aziza; Airey, Rebecca; Dam, Gech Heng; Lu, Man; Flinterman, Marcella; Yong, Queenie; Lee, Tet Woo; Hunter, Francis W; Jamieson, Stephen M F

Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer.

整合转录组学和功能建模揭示了AKT和mTOR在结直肠癌中的协同作用

Duleba Marcin, ZimolÄ g Eliza, Szuszkiewicz Joanna, Serocki Marcin, Szklarczyk Joanna, Dracz Olga, Kurzejamski Alexander, Więckowska Izabella, Chmiel Marcelina, Lipert Barbara, Sarad Katarzyna, Krawczyk Joanna, Bryzghalov Oleksii, Stachowicz-Wałaszek Agata, Pyziak Karolina, Drozdowska Joanna, Baczyński Krzysztof, Wojtowicz Konrad, Chronowski Maurycy, Rataj Krzysztof, Otrocka Magdalena, Mikula Michał, Feliksiak Paula, Dziadziuszko Rafał, Rzymski Tomasz, Thomason Andrew, Brzózka Krzysztof, Mazan Andrzej

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer

HER2阳性乳腺癌对曲妥珠单抗-美坦新(T-DM1)的耐药机制

Hunter, Francis W; Barker, Hilary R; Lipert, Barbara; Rothé, Françoise; Gebhart, Géraldine; Piccart-Gebhart, Martine J; Sotiriou, Christos; Jamieson, Stephen M F

MCPIP1 contributes to clear cell renal cell carcinomas development

MCPIP1促进透明细胞肾细胞癌的发生发展。

Ligeza, Janusz; Marona, Paulina; Gach, Natalia; Lipert, Barbara; Miekus, Katarzyna; Wilk, Waclaw; Jaszczynski, Janusz; Stelmach, Andrzej; Loboda, Agnieszka; Dulak, Jozef; Branicki, Wojciech; Rys, Janusz; Jura, Jolanta